The FDA has expanded Pluvicto’s approval, allowing its use earlier in treatment for PSMA‑positive metastatic hormone‑sensitive prostate cancer, nearly doubling the number of eligible patients.

I’ll be 70 in August, and in 2012, I had prostate cancer. My prostate was removed. My PSA level was low but rose fast, so I guess it was an aggressive form of cancer. After the removal, they still ...

I’ll be 70 in August, and in 2012, I had prostate cancer. My prostate was removed. My PSA level was low but rose fast, so I guess it was an aggressive form of cancer. After the removal, they still ...

Opinion: “We don’t need more men chasing testosterone,” writes Dr. Arthur Burnett. “We need more men pursuing actual health.” ...

A man walks through the afternoon shadows on the tile floor at Grand Central Terminal in New York August 23, 2017. Grand Central Terminal has remained the busiest train station in the country. / AFP ...

A new policy raises questions about testosterone’s effect on aggression in some men. By Azeen Ghorayshi Azeen has interviewed ...

Men’s Health profiled 22 men on testosterone. Charles Flanagan restarted therapy after his levels dropped below 100 ng/dL, a ...

A local soldier and doctor weigh in on the DoD’s new testosterone testing policy and how targeted treatment helped one Fort ...

Hone Health reports millions of Americans face challenges accessing hormone care, particularly in rural areas with few ...

Federal regulators are moving to rewrite the rulebook on testosterone replacement therapy, easing warnings that have shaped ...

The TRAVERSE study was the largest of its kind, enrolling 5,246 men to test if testosterone replacement therapy raises the ...

The FDA is rewriting the safety labels on testosterone replacement therapy for the first time in years, and the shift touches ...